[Turn 3: Agent V3]
field: Analytical chemistry / experimental design
field_rationale: V1 covered synthetic/organometallic gaps (mass balance, mechanistic probe completeness, scope); V2 covered physical organic / radical kinetics gaps (rate constants, redox potentials, kinetic/thermodynamic control). Neither addressed data quality, reproducibility, analytical validation, confounding variables in experimental design, or structural assignment completeness. The paper's primary evidence is isolated yield data in screening tables (Table 1, 13 entries; Table 2, 6 entries) and a suite of probe experiments lacking replicate data or control experiments — signals for an analytical / experimental design perspective. No DFT is present, so computational chemistry is not triggered.

--- New questions ---

V3-Q1
loc: P2:Table1 (caption) / P4:Table2 (caption)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Are any of the yields in Table 1 or Table 2 based on replicate runs? No standard deviations, confidence intervals, or indication of duplicate/triplicate experiments are provided for any entry; it is unclear whether reported yields represent single-run observations or averaged values.
severity: medium
inference_tier: T1

V3-Q2
loc: P2:Table1 (entries 3, 11–13)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Could the temperature difference between standard aza-Heck conditions (60°C, entry 3) and reductive/radical conditions (70–90°C, entries 11–13) independently contribute to the mechanistic switch, confounding the attribution of the divergence solely to ligand choice? No experiment holds temperature constant while varying only the ligand is described.
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q3
loc: P2:Rcol (Table 1 conditions)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What solvent screen was performed, and does the choice of DMF specifically promote the radical pathway by serving as a H-atom donor (as the paper implies in footnote 17)? The paper acknowledges DMF as a hydrogen atom source but does not report experiments in non-HAT-capable solvents under the same electron-rich ligand conditions to isolate the ligand effect from the solvent effect.
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q4
loc: P3:Lcol (Scheme 2A description) / P1:footnote (CCDC 1429194)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What are the crystallographic reliability metrics (R1, wR2, Flack parameter, data completeness) for the X-ray structure of TEMPO adduct 6 (CCDC 1429194)? No crystallographic quality indicators are provided in the main text.
severity: low
inference_tier: T1

V3-Q5
loc: P2:Rcol – P3:Lcol (Table 1 / Scheme 2 section)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Is there a Pd-free control experiment (no catalyst, same temperature and base) to rule out thermal or base-mediated N–O homolysis of oxime esters 1a/b as a source of iminyl radicals independent of Pd? Without this control, Pd-mediated SET cannot be unambiguously distinguished from background radical generation.
severity: high
inference_tier: T2 [paper-grounded inference]

V3-Q6
loc: P2:Table1 (footnote d)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: For Table 1 entries in which both 3a and 5a are reported as <5%, what is the overall conversion of starting material? "Isolated yield" of <5% for both products is consistent with either high conversion to ketone/other products or low conversion overall; GC or 1H NMR yield data for all components would clarify which.
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q7
loc: P3:Lcol (Scheme 2B) / P4:Table2 caption
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: By what analytical method (1H NMR integration, GC with internal standard, isolated weight) were d.r. values (10:1 for 6; >19:1 for 22b; 5.6:1 E:Z for 13b) determined? No analytical method for diastereomeric ratio measurement is specified in the main text.
severity: low
inference_tier: T1

V3-Q8
loc: P4:Lcol (Scheme 4)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: "Complete consumption after 15 minutes" is stated without time-course monitoring data. Are any intermediate time-point aliquots (e.g., TLC, 1H NMR, GC) provided to support this claim and to characterize the fate of the remaining ~50% mass balance?
severity: medium
inference_tier: T1

--- Overlaps with V1/V2 ---

V3-OV1
overlaps_with: V1-Q1
severity_V3: high
note: From an analytical design perspective, the absence of systematic mass balance data (GC yield or NMR yield for all components in Table 1) is a fundamental data quality issue that prevents any quantitative mechanistic interpretation of the ligand screen.

V3-OV2
overlaps_with: V1-Q4
severity_V3: high
note: A 25% isolated yield in a radical clock experiment (Scheme 3A) raises the question of whether yields were measured by 1H NMR or GC before workup; a low isolated yield does not preclude a higher in-situ yield, which would strengthen the mechanistic interpretation.

V3-OV3
overlaps_with: V1-Q7
severity_V3: medium
note: The stoichiometric vs. catalytic comparison (14b vs. 14a in Scheme 4) is a confounded experimental design; from an analytical standpoint, a properly controlled comparison would require matched catalyst loading and the same substrate to isolate the ligand variable.

V3-OV4
overlaps_with: V2-Q1
severity_V3: medium
note: Experimental design requires either kinetic data or activation energy measurements to assign kinetic vs. thermodynamic control of the mechanistic switch; the current design (yield endpoint data only) cannot resolve this.

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
